BioCentury | Mar 30, 2018
Financial News

Adagene raises $50M in series C for antibodies in China

...$50 million in an oversubscribed series C round led by Sequoia China with participation from New World TMT...
BioCentury | Mar 27, 2018
Financial News

Chinese antibody company Adagene raises $50M series C

...$50 million in an oversubscribed series C round led by Sequoia China with participation from New World TMT...
BioCentury | Feb 1, 2016
Financial News

Adagene completes venture financing

...China Business: Antibodies Date completed: 2016-01-28 Type: Venture financing Raised: $28 million Investors: GP Capital; New World TMT...
BioCentury | Jan 29, 2016
Financial News

Chinese antibody play Adagene raises $28M

...series B round led by new investor GP Healthcare Capital. Also participating were new investor New World TMT...
Items per page:
1 - 4 of 4
BioCentury | Mar 30, 2018
Financial News

Adagene raises $50M in series C for antibodies in China

...$50 million in an oversubscribed series C round led by Sequoia China with participation from New World TMT...
BioCentury | Mar 27, 2018
Financial News

Chinese antibody company Adagene raises $50M series C

...$50 million in an oversubscribed series C round led by Sequoia China with participation from New World TMT...
BioCentury | Feb 1, 2016
Financial News

Adagene completes venture financing

...China Business: Antibodies Date completed: 2016-01-28 Type: Venture financing Raised: $28 million Investors: GP Capital; New World TMT...
BioCentury | Jan 29, 2016
Financial News

Chinese antibody play Adagene raises $28M

...series B round led by new investor GP Healthcare Capital. Also participating were new investor New World TMT...
Items per page:
1 - 4 of 4